MATRIX (Microbicide Research and Development (R&D) to Advance HIV Prevention Technologies through Responsive Innovation and Excellence) is a USAID funded 5-year program aimed to develop a range of HIV prevention products that are acceptable, affordable, scalable and deliverable by providing a platform for efficient, benchmark-driven portfolio management. The project is grounded in North-South partnerships that aim to realize and strengthen the capacity of African investigators, health systems and the business sector to lead this work and ensure its sustainability into the future.
CAMI Health, a program of the Public Health Institute, is excited to support the MATRIX program in two activities: Capacity Strengthening and Engagement (CaSE) and Business Market Dynamics and Commercialization (BACH).
The overall goal of CaSE is to enhance capacity and technical skills of scientists and institutions in sub-Saharan Africa in alignment with technical and strategic areas prioritized by MATRIX. CaSE offers early to mid-level career scientists and researchers the exciting opportunity to participate in 1-12 month long fellowships with guidance from leading HIV-prevention experts from the world. CAMI Health is partnered with Aurum Institute and Kenya Medical Research Institute (KEMRI) as co-leads of CaSE.
The overall goal of BACH is to help product developers understand market dynamics and how to structure public health-oriented partnerships can accelerate eventual access to essential products. BACH will also help product developers refine their commercialization strategies, develop their business cases and access plans, and identify complementary resources to advance products to the finish line.
Find current funding and training opportunities through MATRIX listed here.
Other training and career development resources pertinent to CAMI Health’s mission of improving women’s health can be found below.
Active training opportunities for those interested in careers in women’s health and/or sexual and reproductive health are curated and updated regularly.
A special issue of MDPI will focus on innovative drug formulation and drug delivery systems that can help address the unmet health needs of women worldwide. MDPI is now accepting submissions for original manuscripts and review articles that discuss drug delivery systems that address a range of women’s health needs such as vaginal health, contraception and pregnancy, sexually transmitted infections, and genitourinary symptoms of menopause. Guest editors also encourage submissions that address other women’s health issues. Submissions are due 30 September 2022.
RHSC is a global partnership of more than 550 public, private, and non-governmental organizations dedicated to ensuring that all people in low- and middle-income countries can choose, obtain, and use affordable, high-quality supplies and related services to ensure their better sexual and reproductive health (SRH). Their global Secretariat is staffed and managed by PATH, a global nonprofit improving public health. PATH, on behalf of the Coalition Secretariat, is seeking an RHSC Director, who together with the Secretariat and global membership, will advance Coalition goals and priorities under the leadership of the RHSC Executive Committee. Learn more and apply here.
The Male Contraceptive Initiative (MCI) supports the career development of students and research trainees directly through their Success program. MCI accepts applications on a rolling basis for any activity or need that advances the career of a trainee interested in the field of male contraception. Eligible activities include travel grants, digital conferences, workshops, and other professional development opportunities. Contact firstname.lastname@example.org for questions regarding eligibility and apply here!
The Sci-Founder Fellowship program supports early-career scientists in launching their own companies. This program will be investing $400,000 to each founding team to establish their company and includes mentorship from field experts, as well as access to a network of other scientists kickstarting their own groups. Contact email@example.com for questions about the program.
The California Prevention Training Center (CAPTC) hosted an “STD Expert Hour” Webinar Training featuring IMPT Co-Founder & Director, Dr. Bethany Young Holt, in June, 2021. In this training, titled “New Frontiers in STI/HIV Prevention & Family Planning: The Promise of Multipurpose Prevention Technologies”, Dr. Young Holt covers the global need for comprehensive prevention, the origins of MPTs, and the current R&D pipeline for MPTs, including the latest developments in the field. Click here to access the recording, as well as additional CAPTC trainings.